---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-114376"
form_type: "8-K"
ticker: "NVAX"
cik: "0001000694"
company_name: "NOVAVAX INC"
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:03:51.593375+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Novavax settles UK COVID vaccine supply dispute, agrees to pay $123.8M refund

## Summary
- Settlement with UK Health Security Agency resolves all claims related to the Amended and Restated Supply Agreement.
- Company to pay $123.8M in equal quarterly installments of $10.3M over three years, ending June 30, 2027.
- First installment of $10.3M due November 30, 2024 under a Letter of Amendment.
- Total includes $11.3M imputed interest; company may avoid interest by accelerating payments.
- Original supply agreement terminated effective November 1, 2024.

## SEC filing metadata
- accession: 0001104659-24-114376
- form_type: 8-K
- ticker: NVAX
- cik: 0001000694
- company_name: NOVAVAX INC
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 1.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1000694/000110465924114376/0001104659-24-114376-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1000694/000110465924114376/tm2427595d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-114376
- JSON: https://secwatch.observer/filing/0001104659-24-114376.json
- Plain text: https://secwatch.observer/filing/0001104659-24-114376.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.